Skip to main content
logo
Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
3.760
0.00 (0.00%)
At close: Oct 1, 2026, 4:00 PM EDT
3.740
-0.020 (-0.53%)
After-hours: Oct 1, 2026, 7:30 PM EDT

Whitehawk Therapeutics Revenue

In the year 2025, Whitehawk Therapeutics had annual revenue of $7.15M, down -72.50%.

Revenue (ttm)
$7.15M
Revenue Growth
-72.50%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
32
Market Cap
214.35M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20257.15M-18.84M-72.50%
Dec 31, 202425.98M1.63M6.69%
Dec 31, 202324.35M9.14M60.06%
Dec 31, 202215.22M14.10M1,258.57%
Dec 31, 20211.12M-13.46M-92.32%
Dec 31, 202014.58M--
Dec 31, 2019---
Dec 31, 201820.16M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---
Dec 31, 2010---
Dec 31, 2009---
Dec 31, 2008---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Protalix BioTherapeutics80.62M
Compugen74.00M
Foghorn Therapeutics36.74M
Keros Therapeutics15.01M
Alector13.86M
Adagene9.29M
Cartesian Therapeutics1.48M
Revenue Rankings

WHWK News

More News